Results 211 to 220 of about 90,511 (304)

Immune‐Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) are an important treatment option in bladder cancer, but clinical trials have demonstrated that they are associated with immune‐related adverse events (irAEs), such as rash, hypothyroidism, hyperthyroidism, and others. This study aimed to evaluate real‐world evidence of these irAEs using the FDA
Pooja Gokhale, Lorenzo Villa Zapata
wiley   +1 more source

“The Long Road to a Rare Destination”: Ovarian Serous Carcinoma With Late Thymic Metastasis 25 Years After Diagnosis

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT We report a rare case of thymic metastasis of ovarian serous carcinoma. A 72‐year‐old woman who had undergone surgery for low‐grade serous carcinoma of the ovary and had been free of disease for 25 years was noted to have rising CA‐125 levels. Further workup revealed a mediastinal mass on imaging.
Nicole Fye, Nicholas D'Alonzo, Pauline H. Go, Sanica Bhele   +3 more
wiley   +1 more source

Linking physical stimulation to molecular responses: The role and value of exosomes in mediating the systemic effects of Chinese Tuina

Clinical and Translational Discovery, Volume 6, Issue 2, April 2026.
(1) Tuina's mechanical forces activate cellular mechanosensors; (2) Induce multi‐tissue exosome release to mediate intercellular communication; (3) Exosomes systemically regulate muscle, nerve, immune and vascular functions; (4) Target gene knockout confirms exosomes’ specific mediating role.
Lifen Zhan, Ji Zhang, Yiping Chen, Suyu Chen, Xiantao Tai   +4 more
wiley   +1 more source

The effects and toxicity profiles of consolidative and salvage thoracic radiotherapy following chemoimmunotherapy in patients with extensive-stage small cell lung cancer. [PDF]

J Biomed Res
Sun R, Zong D, Chen X, Ge Y, Jiang N, Zhao L, Song X, He X, Zhu X.   +8 more
europepmc   +1 more source

The role of small or single-institution prospective studies in thoracic research [PDF]

, 2019
Frye, C. Corbin, Harrison, M. Shea, Kozower, Benjamin D, Meyers, Bryam F, Puri, Varun, Semenkovich, Tara R, Subramanian, Melanie   +6 more
core   +1 more source

Advances in CT-based lung function imaging for thoracic radiotherapy. [PDF]

Front Oncol
Bi S, Yuan Q, Dai Z, Sun X, Wan Sohaimi WFB, Bin Yusoff AL.   +5 more
europepmc   +1 more source

ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study

Clinical and Translational Medicine, Volume 16, Issue 4, April 2026.
1. Under hypoxia, downregulating the CXCL9:SPP1 ratio in macrophages promoted malignant progression of non‐small cell lung cancer (NSCLC). 2. Transcriptional factor ZFP36L1 modulated the CXCL9:SPP1 macrophage polarity. 3. ZFP36L1‐driven SPP1+ macrophages could accelerate NSCLC progression by binding to CD44 on the tumour cell surface.
Lijie Wang, Biao Chen, Jinxian He, Chengbin Lin, Weiyu Shen, Wang Lv, Luming Wang, Jian Hu   +7 more
wiley   +1 more source

Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients. [PDF]

Cancer Med
Mu X, Zhou Y, Liu Q, Wang J, Xu F, Luo F, Wang K, Li L, Tian P, Li Y, Liu J, Zhang Y, Liu J, Li Y.   +13 more
europepmc   +1 more source

Cytopathologic Features of Metastatic Malignant Mesothelioma With SMARCB1 (INI‐1) Deficient Diagnosed by Ultrasound‐Guided Fine‐Needle Aspiration: A Case Report

Diagnostic Cytopathology, Volume 54, Issue 4, Page E87-E92, April 2026.
ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang, Juandi Liu, Jing Jin, Deng Pan, Lei Shao   +4 more
wiley   +1 more source

Streamlining Thoracic Radiotherapy Quality assurance: One-Class Classification for Automated OAR Contour Assessment. [PDF]

Technol Cancer Res Treat
Zhao Y, Yuan C, Liang Y, Li Y, Li C, Zhao M, Hu J, Zhong N, Liu W, Liu C.   +9 more
europepmc   +1 more source